{
  "retracted": false,
  "timestamp": 1569888000000,
  "updates": [
    {
      "timestamp": 1564715588765,
      "identifier": {
        "doi": "10.1016/j.canlet.2019.05.012"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.canlet.2017.01.035"
  },
  "journal": "Cancer Letters",
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)” [Cancer Lett. 392 (1) (2017) 9–16]"
}
